Exchange Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Buy
1,091
+51
+5% +$52.1K 0.81% 35
2026
Q1
$957K Sell
1,040
-70
-6% -$71K 0.66% 43
2025
Q4
$1.19M Sell
1,110
-104
-9% -$99.4K 0.83% 34
2025
Q3
$926K Buy
1,214
+41
+3% +$30.5K 0.64% 44
2025
Q2
$914K Sell
1,173
-48
-4% -$37.3K 0.72% 40
2025
Q1
$1.01M Buy
1,221
+10
+0.8% +$8.32K 0.81% 36
2024
Q4
$935K Buy
1,211
+222
+22% +$184K 0.75% 38
2024
Q3
$876K Sell
989
-133
-12% -$120K 0.72% 41
2024
Q2
$1.02M Sell
1,122
-41
-4% -$32.8K 0.86% 36
2024
Q1
$905K Sell
1,163
-14
-1% -$9.96K 0.74% 38
2023
Q4
$686K Sell
1,177
-48
-4% -$28K 0.59% 48
2023
Q3
$658K Sell
1,225
-79
-6% -$40.7K 0.63% 46
2023
Q2
$612K Buy
+1,304
New +$547K 0.59% 47

Other funds holding LLY

Exchange Bank's LLY Position: Q2 2026 in Review

Exchange Bank increased its Eli Lilly (LLY) stake by 4.9% in Q2 2026, buying an estimated $52.1K and bringing the position to 1,091 shares worth $1.31M. The position accounts for 0.81% of the portfolio, ranked #35.

Exchange Bank first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Exchange Bank held 1,091 shares of Eli Lilly worth $1.31M as of Q2 2026.
  • Exchange Bank bought 51 Eli Lilly shares in Q2 2026, an estimated $52.1K.
  • Eli Lilly made up 0.81% of Exchange Bank's portfolio in Q2 2026, its #35 holding.
  • Exchange Bank first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Exchange Bank's 13F filing for Q2 2026, filed 9 Jul 2026.